Intra Coronary Autologous Stem Cell Transplantation in Acute Myocardial Infarction (AMI

Global Medical education & Research Center0 个研究点目标入组 50 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Ages Eligible for Study: >21 Years
•Genders Eligible for Study: Both
•Accepts Healthy Volunteers: No
•?Acute ST elevation on MI.
•?CPK-MB above 2 times; upper reference value.
•?Recanalised culprit vessel
•a)After successful PCI with stenting of culprit vessel.
•b)Reanalyzed vessel after thrombolytic therapy with no residual lesion or residual lesion of <50%.
•?Hypokinetic, Akinetic, Dyskinetic segment assessed by 2D-Echocardigraphy in standard 16-segment model.

•?Multi vessel coronary artery disease (established).
•?Previous MI with established significant Q-wave on ECG.
•?Severe hepatic or renal dysfunction (Co-morbid Medical condition).
•?Stroke with significant sequel.
•?HIV/HBS/HCV positive serology.
•?Short life expectancy due to cancer/ terminal illness which influence the patient.
•?Mental disorder which interferes with possibility of Non-compliance with the protocol.
•?Possibility of non-compliance with the protocol.
•?Gross CCF/Pulmonary edema.

发起方

Global Medical education & Research Center